Fidelity European Trust is top capital growth investment over 5 and 10 years

Over both 5 year and 10 year periods, Citywire rank Fidelity European Trust plc (with the LSE ticker LON:FEV) as the top European investment trust by share price performance. It’s share price has grown 73.6% over 5 years from 31/07/2018 to 31/07/2023 and 203.8% over 10 years from 31/07/2013 to 31/07/2023. This makes FEV the number 1 capital growth stock amongst European investment trusts over both periods.

BlackRock Greater Europe Investment is second and Henderson European Focus Trust is third over the same periods.

Source: Citywire Investment Trust insider

June 2023 factsheet commentary

FEV-June-23-factsheet Download

Fidelity European Trust PLC (LON:FEV) is a European investment trust. It aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:

You might also enjoy reading European markets rally on trade optimism and fiscal stimulus

Written by: Amilia Stone

Find more news, interviews, share price & company profile here for:
Fidelity European Trust

Latest Company News

Fidelity European Trust Factsheet – July volatility, Legrand and Bankinter gains

Continental European equities were volatile in July, with the Trust underperforming the index due to weak stock selection in financials and healthcare. Novo Nordisk and ASML detracted, while Legrand and Bankinter contributed positively. Over 12 months, the Trust’s NAV rose 1.8% and the share price 1.7%, compared with an 11.3% gain for the index.

European Investment Opportunities – Fidelity’s Quality Focus (LON:FEV)

FEV portfolio manager Marcel Stotzel highlights how quality companies with strong defensive characteristics can help investors navigate uncertainty and achieve long-term growth.

16.7% YTD return hails Fidelity European Trust’s strong credentials

Despite market headwinds, the Trust demonstrated resilience with standout contributions from Legrand and EQT and positive sector positioning. Over the past 12 months, NAV rose 2.3% and share price 5.5%, reflecting our focus on cash‑generative, dividend‑growing companies.